X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs DIVIS LABORATORIES - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH DIVIS LABORATORIES STERLING BIOTECH/
DIVIS LABORATORIES
 
P/E (TTM) x -0.4 33.8 - View Chart
P/BV x 0.0 6.1 0.3% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 STERLING BIOTECH   DIVIS LABORATORIES
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
DIVIS LABORATORIES
Mar-17
STERLING BIOTECH/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs111,222 0.9%   
Low Rs3784 0.4%   
Sales per share (Unadj.) Rs26.8153.1 17.5%  
Earnings per share (Unadj.) Rs-15.039.9 -37.4%  
Cash flow per share (Unadj.) Rs-5.544.6 -12.3%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs54.9201.8 27.2%  
Shares outstanding (eoy) m267.87265.47 100.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.36.6 4.0%   
Avg P/E ratio x-0.525.1 -1.9%  
P/CF ratio (eoy) x-1.322.5 -5.7%  
Price / Book Value ratio x0.15.0 2.5%  
Dividend payout %025.0 0.0%   
Avg Mkt Cap Rs m1,862266,266 0.7%   
No. of employees `0001.49.7 13.9%   
Total wages/salary Rs m5474,687 11.7%   
Avg. sales/employee Rs Th5,303.34,175.0 127.0%   
Avg. wages/employee Rs Th403.8481.5 83.9%   
Avg. net profit/employee Rs Th-2,959.01,089.3 -271.6%   
INCOME DATA
Net Sales Rs m7,18140,643 17.7%  
Other income Rs m43749 5.7%   
Total revenues Rs m7,22341,392 17.5%   
Gross profit Rs m94714,460 6.5%  
Depreciation Rs m2,5431,233 206.2%   
Interest Rs m4,37723 19,367.7%   
Profit before tax Rs m-5,93113,953 -42.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9243,349 -57.5%   
Profit after tax Rs m-4,00710,604 -37.8%  
Gross profit margin %13.235.6 37.1%  
Effective tax rate %32.424.0 135.2%   
Net profit margin %-55.826.1 -213.9%  
BALANCE SHEET DATA
Current assets Rs m14,33540,105 35.7%   
Current liabilities Rs m49,8096,595 755.3%   
Net working cap to sales %-494.082.5 -599.2%  
Current ratio x0.36.1 4.7%  
Inventory Days Days403119 340.3%  
Debtors Days Days17181 211.5%  
Net fixed assets Rs m55,43219,995 277.2%   
Share capital Rs m268531 50.5%   
"Free" reserves Rs m13,93553,043 26.3%   
Net worth Rs m14,70153,574 27.4%   
Long term debt Rs m9,4780-   
Total assets Rs m73,98861,585 120.1%  
Interest coverage x-0.4618.4 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.10.7 14.7%   
Return on assets %0.517.3 2.9%  
Return on equity %-27.319.8 -137.7%  
Return on capital %-6.426.1 -24.6%  
Exports to sales %25.90-   
Imports to sales %0.225.2 0.7%   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m1210,259 0.1%   
Fx inflow Rs m1,86035,384 5.3%   
Fx outflow Rs m2510,399 0.2%   
Net fx Rs m1,83524,985 7.3%   
CASH FLOW
From Operations Rs m1,71911,493 15.0%  
From Investments Rs m-3,148-11,372 27.7%  
From Financial Activity Rs m1,426-93 -1,531.7%  
Net Cashflow Rs m-328 -12.0%  

Share Holding

Indian Promoters % 33.9 52.0 65.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.8 -  
FIIs % 9.9 19.0 52.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 17.2 228.5%  
Shareholders   21,482 31,796 67.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   CIPLA  SANOFI INDIA  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare STERLING BIOTECH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Nifty Crosses 11,500-Mark; L&T Surges 4% on Buyback News(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.2% while the Hang Seng is up 0.7%.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY19); Net Profit Up 50.8% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 50.8% YoY). Sales on the other hand came in at Rs 10 bn (up 21.2% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY18); Net Profit Up 0.9% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.9% YoY). Sales on the other hand came in at Rs 11 bn (up 2.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 20, 2018 10:47 AM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS